Suppr超能文献

微小RNA-363-3p通过靶向SSFA2抑制口腔鳞状细胞癌细胞系中的肿瘤细胞增殖和侵袭。

MicroRNA-363-3p inhibits tumor cell proliferation and invasion in oral squamous cell carcinoma cell lines by targeting SSFA2.

作者信息

Zhu Liangming, Zhang Lei, Tang Ying, Zhang Fang, Wan Chao, Xu Liang, Guo Ping

机构信息

Department of Stomatology, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241000, P.R. China.

Jiangcheng Dental Clinic, Wuhu, Anhui 241000, P.R. China.

出版信息

Exp Ther Med. 2021 Jun;21(6):549. doi: 10.3892/etm.2021.9981. Epub 2021 Mar 24.

Abstract

The aim of the present study was to evaluate the expression levels of microRNA (miR)-363-3p and its underlying physiological function in oral squamous cell carcinoma (OSCC). miR-363-3p expression levels were measured in OSCC cell lines using reverse transcription-quantitative PCR. The role of miR-363-3p in OSCC cells was examined using gain-of-function assays . Cell proliferation was assessed using Cell Counting Kit-8, 5-ethynyl-2'-deoxyuridine assays and flow cytometry. Cell migration and invasion were evaluated in wound-healing and Transwell Matrigel assays. In addition, bioinformatics analysis predicted binding sites of miR-363-3p on sperm-specific antigen 2 (SSFA2). Luciferase reporter and RNA pull-down assays were conducted to test whether miR-363-3p interacted with SSFA2. miR-363-3p expression was downregulated in OSCC cell lines compared with that in the normal epithelial cell line (NHOK). Additionally, miR-363-3p overexpression suppressed OSCC cell proliferation, migration and invasion . SSFA2 was verified as a direct target of miR-363-3p, and SSFA2 overexpression partially counteracted the inhibitory effects of miR-363-3p on cell proliferation, migration and invasion in OSCC cell lines. Thus, miR-363-3p may serve as a tumor suppressor via targeting SSFA2 and may represent a potential therapeutic target for OSCC.

摘要

本研究的目的是评估微小RNA(miR)-363-3p在口腔鳞状细胞癌(OSCC)中的表达水平及其潜在的生理功能。使用逆转录定量PCR检测OSCC细胞系中miR-363-3p的表达水平。使用功能获得性试验检测miR-363-3p在OSCC细胞中的作用。使用细胞计数试剂盒-8、5-乙炔基-2'-脱氧尿苷试验和流式细胞术评估细胞增殖。在伤口愈合试验和Transwell基质胶试验中评估细胞迁移和侵袭。此外,生物信息学分析预测了miR-363-3p在精子特异性抗原2(SSFA2)上的结合位点。进行荧光素酶报告基因试验和RNA下拉试验以检测miR-363-3p是否与SSFA2相互作用。与正常上皮细胞系(NHOK)相比,OSCC细胞系中miR-363-3p的表达下调。此外,miR-363-3p过表达抑制了OSCC细胞的增殖、迁移和侵袭。SSFA2被证实为miR-363-3p的直接靶点,并且SSFA2过表达部分抵消了miR-363-3p对OSCC细胞系中细胞增殖、迁移和侵袭的抑制作用。因此,miR-363-3p可能通过靶向SSFA2发挥肿瘤抑制作用,并且可能代表OSCC的潜在治疗靶点。

相似文献

3
MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.
Oncol Lett. 2019 Jan;17(1):688-696. doi: 10.3892/ol.2018.9637. Epub 2018 Oct 29.
4
MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
J Cell Biochem. 2018 Jan;119(1):338-346. doi: 10.1002/jcb.26182. Epub 2017 Jun 27.
5
MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6927-6934. doi: 10.26355/eurrev_201908_18732.
6
MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B.
J Oral Pathol Med. 2020 Aug;49(7):621-629. doi: 10.1111/jop.12986. Epub 2020 Mar 1.
9
IP3R1 dysregulation via mir-200c-3p/SSFA2 axis contributes to taxol resistance in head and neck cancer.
Eur J Pharmacol. 2024 Jun 15;973:176592. doi: 10.1016/j.ejphar.2024.176592. Epub 2024 Apr 18.
10
Long Non-Coding RNA LINC01929 Accelerates Progression of Oral Squamous Cell Carcinoma by Targeting the miR-137-3p/FOXC1 Axis.
Front Oncol. 2021 Apr 21;11:657876. doi: 10.3389/fonc.2021.657876. eCollection 2021.

引用本文的文献

1
Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth and in a murine model.
Front Oncol. 2023 Feb 17;13:1087644. doi: 10.3389/fonc.2023.1087644. eCollection 2023.
3
miRNA-877-5p inhibits malignant progression of prostate cancer by directly targeting SSFA2.
Eur J Histochem. 2021 Sep 20;65(3):3243. doi: 10.4081/ejh.2021.3243.

本文引用的文献

2
Molecular mechanism of SSFA2 deletion inhibiting cell proliferation and promoting cell apoptosis in glioma.
Pathol Res Pract. 2019 Mar;215(3):600-606. doi: 10.1016/j.prp.2018.12.035. Epub 2018 Dec 31.
3
MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2.
Biomed Pharmacother. 2018 Sep;105:922-931. doi: 10.1016/j.biopha.2018.06.052. Epub 2018 Jun 19.
4
Oncogene-induced regulation of microRNA expression: Implications for cancer initiation, progression and therapy.
Cancer Lett. 2018 May 1;421:152-160. doi: 10.1016/j.canlet.2018.02.029. Epub 2018 Feb 21.
5
MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
Mol Med Rep. 2018 Mar;17(3):4003-4010. doi: 10.3892/mmr.2017.8299. Epub 2017 Dec 18.
6
Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.
Mod Pathol. 2017 Oct;30(10):1387-1401. doi: 10.1038/modpathol.2017.62. Epub 2017 Jul 21.
7
MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.
Cancer Med. 2017 Jul;6(7):1686-1697. doi: 10.1002/cam4.1110. Epub 2017 Jun 19.
8
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.
Mod Pathol. 2017 Aug;30(8):1116-1125. doi: 10.1038/modpathol.2017.35. Epub 2017 May 26.
10
miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
Oncotarget. 2017 Mar 21;8(12):20133-20144. doi: 10.18632/oncotarget.15448.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验